Efficacy and Safety of a Combined Oral Contraceptive Containing Estradiol Valerate/Dienogest: Results from a Clinical Study Conducted in North AmericaNELSON, Anita; PARKE, Susanne; MELLINGER, Uwe et al.Journal of women's health (Larchmont, N.Y. 2002). 2014, Vol 23, Num 3, pp 204-210, issn 1540-9996, 7 p.Article

A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal womenENDRIKAT, Jan; GRAESER, Thomas; MELLINGER, Uwe et al.Maturitas (Amsterdam). 2007, Vol 58, Num 2, pp 201-207, issn 0378-5122, 7 p.Article

Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest: A Randomized Controlled TrialJENSEN, Jeffrey T; PARKE, Susanne; MELLINGER, Uwe et al.Obstetrics and gynecology (New York. 1953). 2011, Vol 117, Num 4, pp 777-787, issn 0029-7844, 11 p.Article

Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal womenBLODE, Hartmut; ZEUN, Susan; PARKE, Susanne et al.Contraception (Stoneham). 2012, Vol 86, Num 4, pp 337-344, issn 0010-7824, 8 p.Article

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study populationGERLINGER, Christoph; TRUSSELL, James; MELLINGER, Uwe et al.Contraception (Stoneham). 2014, Vol 90, Num 2, pp 142-146, issn 0010-7824, 5 p.Article

Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogestFRASER, Ian S; JENSEN, Jeffrey; SCHAEFERS, Matthias et al.Contraception (Stoneham). 2012, Vol 86, Num 2, pp 96-101, issn 0010-7824, 6 p.Article

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrelAHRENDT, Hans-Joachim; MAKALOVA, Dagmar; PARKE, Susanne et al.Contraception (Stoneham). 2009, Vol 80, Num 5, pp 436-444, issn 0010-7824, 9 p.Article

Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacyWIEGRATZA, Inka; STAHLBERG, Skadi; MANTHEY, Torsten et al.Contraception (Stoneham). 2011, Vol 84, Num 2, pp 133-143, issn 0010-7824, 11 p.Article

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters : conventional vs. extended-cycle useSÄNGER, Nicole; STAHLBERG, Skadi; MANTHEY, Torsten et al.Contraception (Stoneham). 2008, Vol 77, Num 6, pp 420-425, issn 0010-7824, 6 p.Article

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle useWIEGRATZ, Inka; STAHLBERG, Skadi; MANTHEY, Torsten et al.Contraception (Stoneham). 2010, Vol 81, Num 1, pp 57-61, issn 0010-7824, 5 p.Article

Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parametersWIEGRATZ, Inka; STAHLBERG, Skadi; MANTHEY, Torsten et al.Contraception (Stoneham). 2008, Vol 78, Num 5, pp 384-391, issn 0010-7824, 8 p.Article